Related Experiment Video
Updated: May 18, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Ferumoxytol-enhanced MRI to Image Inflammation within Human Brain Arteriovenous Malformations: A Pilot Investigation
David M Hasan1, Matthew Amans, Tarik Tihan
1Department of Neurosurgery, Carver College of Medicine, University of Iowa, Iowa City, IA.
Abstract:
Inflammation cell infiltration and cytokine expression are seen in the vascular walls and intervening stroma of resected brain arteriovenous malformation (bAVM) specimens, even in unruptured and previously untreated lesions. Macrophages may play a critical role in bAVM progression to rupture, and could serve as a marker for rupture risk. We assessed feasibility of imaging macrophages within the bAVM nidus using ferumoxytol-enhanced MRI in four patients with already diagnosed bAVMs using iron-sensitive imaging (ISI; T2*-GE-MRI sequence). Patients were imaged at baseline and at either 1 day (n=2) or 5 days (n=2) after infusion of 5mg/kg of ferumoxytol. Residual intravascular ferumoxytol obscured evaluation for uptake in bAVM vascular walls and stroma at the 1-day time point. The two cases imaged at 5 days showed less intravascular tracer but had signal loss in the nidal region consistent with ferumoxytol localization. One case underwent surgical resection; there was prominent vascular wall CD68 staining. Ferumoxytol-enhanced-MRI for assessing bAVM inflammatory cell burden appears feasible and has the potential to be developed as a biomarker to study lesional inflammatory events.
Insights
Macrophages in brain arteriovenous malformations (bAVMs) may drive rupture. Ferumoxytol-enhanced MRI shows potential for imaging these inflammatory cells, offering a new biomarker for bAVM rupture risk.
Area of Science:
- Neuroimaging
- Vascular Biology
- Immunology
Background:
- Brain arteriovenous malformations (bAVMs) exhibit inflammation, including macrophages, even in untreated lesions.
- Macrophages are implicated in bAVM progression and may indicate rupture risk.
Purpose of the Study:
- To assess the feasibility of imaging macrophages within bAVMs using ferumoxytol-enhanced MRI.
- To explore ferumoxytol-enhanced MRI as a potential biomarker for bAVM inflammation.
Main Methods:
- Four patients with diagnosed bAVMs underwent ferumoxytol-enhanced MRI using iron-sensitive imaging (T2*-GE-MRI).
- Imaging was performed at baseline and 1 or 5 days post-ferumoxytol infusion (5mg/kg).
- Histopathological correlation (CD68 staining) was performed on one resected specimen.
Main Results:
- Imaging at 5 days post-infusion showed reduced intravascular ferumoxytol and signal loss in the bAVM nidus, suggesting tracer localization.
- One patient showed prominent CD68 staining in the vascular wall upon resection, correlating with imaging findings.
- Early imaging (1 day) was limited by residual intravascular ferumoxytol.
Conclusions:
- Ferumoxytol-enhanced MRI is a feasible technique for visualizing inflammatory cells, specifically macrophages, within bAVMs.
- This imaging approach holds promise for developing a non-invasive biomarker to assess bAVM inflammatory burden and rupture risk.
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies VII: Vascular Imaging
